Cresud SA (CRES)
Buenos Aires Exchange · Argentina · prices in ARS · close of 22 Oct 2026
Key indicators
| Last close | ARS 1,784.00 |
|---|---|
| 52-week range | 1,397.00 – 2,210.00 |
| Return, 1 month / 3 months | −10.8% / −2.8% |
| Return, 1 year / 3 years | +20.1% / +107.2% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 41 |
| Volatility (1 year) | 38.6% |
| Worst drawdown (1 year) | -26.2% |
| Average daily value traded | 503.53M ARS |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Cresud is an Argentine agricultural company based in Buenos Aires. It owns and works farmland, growing crops such as grains and oilseeds and raising cattle for beef production. Its operations are spread across several regions of Argentina, and the company also has interests in agricultural land development in Brazil through a related business. Its customers are mainly buyers of agricultural commodities and livestock, along with tenants and partners involved in farming and land development.
The shares are listed on the Buenos Aires Exchange in Argentina under the code CRES, and the price on this page is in Argentine pesos (ARS). Our dividend records, which start in 2019, show payments in one calendar year. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Cresud SA (CRES) trades on the Buenos Aires Exchange in Argentina. It last closed at ARS 1,784.00 on 22 October 2026.
Its price-based Market X-Ray is 57 out of 100 (a fair price profile), ranking 62 of 154 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 20.1% and over the last three months it fell 2.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Buenos Aires Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 53 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 0.1% | ||
| From 52-week high | -15.8% | ||
| Momentum | 56 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -2.8% | ||
| 6-month return | 7.8% | ||
| 12-month return, skipping the last month | 34.6% | ||
| Stability (higher is calmer) | 56 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 38.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -26.2% | ||
| Liquidity | 69 · Fair | Moderate trading activity. | |
| Average daily value traded | 503.53M ARS | ||
| Zero-volume days | 1.7% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 1 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −3.0% |
|---|---|
| 1 month | −10.8% |
| 3 months | −2.8% |
| 6 months | +7.8% |
| 1 year | +20.1% |
| 3 years | +107.2% |
| 5 years | +1,528.1% |
Signals
| 50-day / 200-day average | 1,863.92 / 1,782.69 |
|---|---|
| Golden / death cross (60 days) | Golden, 27 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 71.93 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 9 Nov 2022 | ARS 5.2866 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Buenos Aires Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.